Skip to main content
. 2021 Mar 31;5(2):BJGPO.2020.0104. doi: 10.3399/BJGPO.2020.0104

Table 3. Indication for valproate for women included in the first and last quarters of the study period.

Valproateindicationa Dataextraction from 1 Oct 2017 Data extraction from 1 Jan 2020
n (%) n (%)
Epilepsy 139 (65) 88 (65)
Bipolar disorder 31 (14) 20 (15)
Migraine 4 (2) 2 (1)
Learning difficulties 5 (2) 5 (4)
Other or unknown 35 (16) 21 (15)
Total patients 214 (100) 136 (100)

aLikely indication inferred from recorded long-term conditions on electronic health record.